Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Ferrante

Showing results (221-230 of 350) with videos related to

Pageof 35
Sort By:
European Journal of Gastroenterology & Hepatology|August 18, 2020
Endoscopic remission can be predicted by golimumab concentrations in patients with ulcerative colitis treated with the changed labelSebastian Stefanovic, Iris Detrez, Griet Compernolle, et al.
Journal of Crohn'S & Colitis|June 13, 2024
Early and Sustained Symptom Control with Mirikizumab in Patients with Ulcerative Colitis in the Phase 3 LUCENT ProgrammeSilvio Danese, Axel Dignass, Katsuyoshi Matsuoka, et al.
Expert Opinion on Drug Safety|July 21, 2022
Safety and tolerability of spesolimab in patients with ulcerative colitisMarc Ferrante, Peter M Irving, Christian P Selinger, et al.
European Radiology|May 17, 2019
Deep learning for liver tumor diagnosis part II: convolutional neural network interpretation using radiologic imaging featuresClinton J Wang, Charlie A Hamm, Lynn J Savic, et al.
Inflammatory Bowel Diseases|April 19, 2018
Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis: a Real-World Belgian Cohort StudySaartje Van de Vondel, Filip Baert, Christine Reenaers, et al.
Gastroenterology|August 12, 2009
Influence of trough serum levels and immunogenicity on long-term outcome of adalimumab therapy in Crohn's diseaseKonstantinos Karmiris, Gilles Paintaud, Maja Noman, et al.
European Radiology|April 25, 2019
Deep learning for liver tumor diagnosis part I: development of a convolutional neural network classifier for multi-phasic MRICharlie A Hamm, Clinton J Wang, Lynn J Savic, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 7, 2018
No Change in Determining Crohn's Disease Recurrence or Need for Endoscopic or Surgical Intervention With Modification of the Rutgeerts' Scoring SystemPauline Rivière, Séverine Vermeire, Marie Irles-Depe, et al.
Journal of Crohn'S & Colitis|March 30, 2016
Long-Term Outcome of Patients with Ulcerative Colitis and Primary Non-response to InfliximabKonstantinos Papamichael, Oliviane Rivals-Lerebours, Thomas Billiet, et al.
Scandinavian Journal of Gastroenterology|November 2, 2020
Worries and concerns of inflammatory bowel disease (IBD) patients in Belgium - a validation of the Dutch rating formMarta Walentynowicz, Iris Van de Pavert, Sofie Coenen, et al.
Pageof 35

Showing results (221-230 of 350) with videos related to

Sort By:
Pageof 35
European Journal of Gastroenterology & Hepatology|August 18, 2020
Endoscopic remission can be predicted by golimumab concentrations in patients with ulcerative colitis treated with the changed labelSebastian Stefanovic, Iris Detrez, Griet Compernolle, et al.
Journal of Crohn'S & Colitis|June 13, 2024
Early and Sustained Symptom Control with Mirikizumab in Patients with Ulcerative Colitis in the Phase 3 LUCENT ProgrammeSilvio Danese, Axel Dignass, Katsuyoshi Matsuoka, et al.
Expert Opinion on Drug Safety|July 21, 2022
Safety and tolerability of spesolimab in patients with ulcerative colitisMarc Ferrante, Peter M Irving, Christian P Selinger, et al.
European Radiology|May 17, 2019
Deep learning for liver tumor diagnosis part II: convolutional neural network interpretation using radiologic imaging featuresClinton J Wang, Charlie A Hamm, Lynn J Savic, et al.
Inflammatory Bowel Diseases|April 19, 2018
Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis: a Real-World Belgian Cohort StudySaartje Van de Vondel, Filip Baert, Christine Reenaers, et al.
Gastroenterology|August 12, 2009
Influence of trough serum levels and immunogenicity on long-term outcome of adalimumab therapy in Crohn's diseaseKonstantinos Karmiris, Gilles Paintaud, Maja Noman, et al.
European Radiology|April 25, 2019
Deep learning for liver tumor diagnosis part I: development of a convolutional neural network classifier for multi-phasic MRICharlie A Hamm, Clinton J Wang, Lynn J Savic, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 7, 2018
No Change in Determining Crohn's Disease Recurrence or Need for Endoscopic or Surgical Intervention With Modification of the Rutgeerts' Scoring SystemPauline Rivière, Séverine Vermeire, Marie Irles-Depe, et al.
Journal of Crohn'S & Colitis|March 30, 2016
Long-Term Outcome of Patients with Ulcerative Colitis and Primary Non-response to InfliximabKonstantinos Papamichael, Oliviane Rivals-Lerebours, Thomas Billiet, et al.
Scandinavian Journal of Gastroenterology|November 2, 2020
Worries and concerns of inflammatory bowel disease (IBD) patients in Belgium - a validation of the Dutch rating formMarta Walentynowicz, Iris Van de Pavert, Sofie Coenen, et al.
Pageof 35